ASSESSING THE BENEFIT OF CONTINUOUS TREATMENT IN THE FIRST TRIAL (MM-020): IMPACT OF RESPONSE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

被引:0
|
作者
Bahlis, N. [1 ]
Corso, A. [2 ]
Muegge, L. O. [3 ]
Shen, Z. X. [4 ]
Desjardins, P. [5 ]
Stoppa, A. M. [6 ]
Decaux, O. [7 ]
de Revel, T. [8 ]
Granell, M. [9 ]
Marit, G. [10 ]
Nahi, H. [11 ]
Demuynck, H. [12 ]
Huang, S. Y. [13 ]
Basu, S. [14 ]
Ervin-Haynes, A. [15 ]
Leupin, N. [15 ]
Marek, J. [15 ]
Chen, G. [15 ]
Facon, T. [16 ]
机构
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Policlin San Mateo Univ Pavia, Pavia, Italy
[3] Univ Klinikum Jena, Klink Inner Med 2, Jena, Germany
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China
[5] Hop Charles Lemoyne, Longueuil, PQ, Canada
[6] Inst J Paoli I Calmettes, F-13009 Marseille, France
[7] CHRU Hosp Sod Med Interne, Rennes, France
[8] Hop Instruct Armees Percy, Paris, France
[9] Hosp Santa Cree & St Pau, Barcelona, Spain
[10] CHU Bordeaux Hop Haut Leveque, Pessac, France
[11] Karolinska Univ, Huddinge Hosp, Solana, Sweden
[12] Jan Yperman Hosp VZW, Leper, Belgium
[13] Natl Taiwan Univ Hosp, Taipei, Taiwan
[14] New Cross Hosp, Wolverhampton, W Midlands, England
[15] Celgene Corp, Summit, NJ USA
[16] Hop Claude Huriez, Serv Malad Sang, Lille, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P277
引用
收藏
页码:85 / 86
页数:2
相关论文
共 50 条
  • [1] A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
    Thierry Facon
    Meletios A. Dimopoulos
    Nathalie Meuleman
    Andrew Belch
    Mohamad Mohty
    Wen-Ming Chen
    Kihyun Kim
    Elena Zamagni
    Paula Rodriguez-Otero
    William Renwick
    Christian Rose
    Adrian Tempescul
    Eileen Boyle
    Salomon Manier
    Michel Attal
    Philippe Moreau
    Margaret Macro
    Xavier Leleu
    Marie Lorraine Chretien
    Heinz Ludwig
    Shien Guo
    Michael Sturniolo
    Antoine Tinel
    Mara Silvia Monzini
    Bruno Costa
    Vanessa Houck
    Cyrille Hulin
    Jean Yves Mary
    Leukemia, 2020, 34 : 224 - 233
  • [2] A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
    Facon, Thierry
    Dimopoulos, Meletios A.
    Meuleman, Nathalie
    Belch, Andrew
    Mohty, Mohamad
    Chen, Wen-Ming
    Kim, Kihyun
    Zamagni, Elena
    Rodriguez-Otero, Paula
    Renwick, William
    Rose, Christian
    Tempescul, Adrian
    Boyle, Eileen
    Manier, Salomon
    Attal, Michel
    Moreau, Philippe
    Macro, Margaret
    Leleu, Xavier
    Chretien, Marie Lorraine
    Ludwig, Heinz
    Guo, Shien
    Sturniolo, Michael
    Tinel, Antoine
    Monzini, Mara Silvia
    Costa, Bruno
    Houck, Vanessa
    Hulin, Cyrille
    Mary, Jean Yves
    LEUKEMIA, 2020, 34 (01) : 224 - 233
  • [3] Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial
    Avet-Loiseau, Herve
    Hulin, Cyrille
    Benboubker, Lofti
    Dimopoulos, Meletios A.
    Belch, Andrew
    Reece, Donna
    Catalano, John
    Pinto, Antonio
    Ludwig, Heinz
    Bahlis, Nizar J.
    Cavo, Michele
    Attal, Michel
    Moreau, Philippe
    Qiu, Lugui
    LeBlanc, Richard
    Schots, Rik
    Rajkumar, S. Vincent
    Marek, Jennifer
    Chen, Guang
    Yiu, Wai
    Ervin-Haynes, Annette
    Facon, Thierry
    BLOOD, 2015, 126 (23)
  • [4] A FRAILTY SCALE PREDICTS OUTCOMES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN THE FIRST (MM-020) TRIAL
    Facon, T.
    Hulin, C.
    Dimopoulos, M. A.
    Belch, A.
    Meuleman, N.
    Mohty, M.
    Chen, W. M.
    Kim, K.
    Zamagni, E.
    Rodriguez-Otero, P.
    Renwick, W.
    Rose, C.
    Tempescul, A.
    Boyle, E.
    Palumbo, A.
    Guo, S.
    Monzini, M. S.
    Sturniolo, M.
    Ervin-Haynes, A.
    Fermand, J. P.
    HAEMATOLOGICA, 2016, 101 : 258 - 259
  • [5] Quadruplets in newly diagnosed transplant-ineligible multiple myeloma
    Chakraborty, Rajshekhar
    Mian, Hira
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (11) : 2249 - 2252
  • [6] Continuous Treatment with Lenalidomide and Low-Dose Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma in Asia: Subanalysis of the First Trial
    Lu, Jin
    Lee, Jae Hoon
    Huang, Shang-Yi
    Qiu, Lugui
    Lee, Je-Jung
    Liu, Ting
    Yoon, Sung-Soo
    Kim, Kihyun
    Shen, Zhi Xiang
    Eom, HyeonSeok
    Chen, Wenming
    Min, Chang-Ki
    Kim, Hyo Jung
    Lee, Jeong Ok
    Kwak, Jae Yong
    Yiu, Wai
    Chen, Guang
    Haynes, Annette Ervin
    Hulin, Cyrille
    Facon, Thierry
    BLOOD, 2015, 126 (23)
  • [7] Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial
    Lu, Jin
    Lee, Jae H.
    Huang, Shang-Yi
    Qiu, Lugui
    Lee, Je-Jung
    Liu, Ting
    Yoon, Sung-Soo
    Kim, Kihyun
    Shen, Zhi X.
    Eom, Hyeon S.
    Chen, Wen M.
    Min, Chang K.
    Kim, Hyo J.
    Lee, Jeong O.
    Kwak, Jae Y.
    Yiu, Wai
    Chen, Guang
    Ervin-Haynes, Annette
    Hulin, Cyrille
    Facon, Thierry
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 743 - 749
  • [8] Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial
    Bahlis, Nizar J.
    Corso, Alessandro
    Mugge, Lars-Olof
    Shen, Zhi-Xiang
    Desjardins, Pierre
    Stoppa, Anne-Marie
    Decaux, Olivier
    De Revel, Thierry
    Granell, Miquel
    Marit, Gerald
    Nahi, Hareth
    Demuynck, Hilde
    Huang, Shang-Yi
    Basu, Supratik
    Guthrie, Troy H.
    Ervin-Haynes, Annette
    Leupin, Nicolas
    Marek, Jennifer
    Chen, Guang
    Facon, Thierry
    BLOOD, 2014, 124 (21)
  • [9] Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma
    Fonseca, Rafael
    Facon, Thierry
    Hashim, Mahmoud
    Nair, Sandhya
    He, Jianming
    Ammann, Eric
    Lam, Annette
    Wildgust, Mark
    Kumar, Shaji
    ONCOLOGIST, 2023, 28 (05): : E263 - E269
  • [10] The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
    Bonello, Francesca
    Grasso, Mariella
    D'Agostino, Mattia
    Celeghini, Ivana
    Castellino, Alessia
    Boccadoro, Mario
    Bringhen, Sara
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 14